Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
《大行》里昂:中國醫療健康板塊近期回調屬買入機會 海外及內地趨勢改善

2026-10-28T  
中生製藥兩款乙肝新藥獲納入突破性治療藥物程序

2026-10-27T  
《業績》石四藥首三季純利按年增15.5%

2026-10-26T  
中生製藥發布自研創新藥TQB2102臨床數據

2026-10-26T  
《輪動華泰》恆指二萬三關下反覆 小米早市曾升5%

2026-10-23T  
美國擬收緊對中國AI及生物科技等敏感領域投資規定 金斯瑞急插13%

2026-10-23T  
和鉑醫藥巴托利單抗皮下注射獲批准上市 治療全身型重症肌無力

2026-10-23T  
石藥集團SYH2066片及SYS6043在中國啟動臨床試驗

2026-10-23T  
中生製藥周四回購1,000萬股 涉近5,000萬元

2026-10-22T  
《大行》瑞銀降聯邦制藥評級至「中性」 重申先聲藥業為首選

2026-10-22T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.